𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study

✍ Scribed by Bengt Winblad; Lena Kilander; Sture Eriksson; Lennart Minthon; Stellan Båtsman; Anna-Lena Wetterholm; Catarina Jansson-Blixt; Anders Haglund

Book ID
117298913
Publisher
The Lancet
Year
2006
Tongue
English
Weight
169 KB
Volume
367
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 24-week, double-blind, placebo-control
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study
✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This